Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02236195
What this trial is testing

Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

Who this might be right for
Urothelial Carcinoma
Mirati Therapeutics Inc. 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562311
What this trial is testing

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder Cancer Stage IV
Sun Yat-sen University 45
Not applicableUnknownNCT04567719
What this trial is testing

Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Kansas Medical Center 9
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Large-scale testing (Phase 3)Active Not RecruitingNCT02170090
What this trial is testing

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Universitätsklinikum Hamburg-Eppendorf 789
Not applicableStudy completedNCT01918592
What this trial is testing

PET/MRI and Biomarkers in Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 25
Post-approval studies (Phase 4)UnknownNCT05701332
What this trial is testing

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

Who this might be right for
Urothelial Carcinoma BladderSperm Count, LowTestis; Fibrosis
Assiut University 25
Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Not applicableStudy completedNCT04723121
What this trial is testing

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Who this might be right for
Bladder Cancer
Mansoura University 204
Early research (Phase 1)Active Not RecruitingNCT05567185
What this trial is testing

Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsReceptors, Fibroblast Growth Factor
Janssen Pharmaceutical K.K. 5
Not applicableLooking for participantsNCT07514897
What this trial is testing

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Who this might be right for
Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 250
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Testing effectiveness (Phase 2)Active Not RecruitingNCT04863885
What this trial is testing

Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Who this might be right for
Metastatic Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 46
Early research (Phase 1)UnknownNCT00959868
What this trial is testing

Treatment of Superficial Bladder Cancer Using OGX-427

Who this might be right for
Bladder Cancer
Vancouver Coastal Health 36
Testing effectiveness (Phase 2)UnknownNCT03529890
What this trial is testing

Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Cancer
Technical University of Munich 33
Not applicableNot Yet RecruitingNCT06325423
What this trial is testing

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Assiut University 50
Post-approval studies (Phase 4)UnknownNCT05631080
What this trial is testing

Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage IBladder Outlet Obstruction
Mansoura University 50
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Not applicableStudy completedNCT05643963
What this trial is testing

The COOKER-BLADDER Trial

Who this might be right for
Diet, HealthyUrinary Bladder DiseasesOncogenesis
Roland Seiler-Blarer 13
Next Page